HIGHFDA DEVICE

CorNeat Vision EverPatch Recalled for Conjunctival Wound Dehiscence Risk (630 Units, 2025)

CorNeat Vision recalled 630 EverPatch surgical matrices distributed worldwide, including in 28 U.S. states. Review of complaints found conjunctival wound dehiscence may lead to early exposure of the patch. Stop using the device immediately and follow the manufacturer’s recall instructions. Contact CORNEAT VISION, LTD. or your healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
August 18, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 18, 2025
Hazard Level
HIGH
Brand
CorNeat Vision
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CorNeat Vision
Product type
Permanent Tissue-Integrating Surgical Matrix
Model numbers
All Lots/ UDI: G16010362950
Sizes
5.0 mm x 605 mm x 100 µm
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 18, 2025

  2. Reported by FDA DEVICE

    October 15, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact CORNEAT VISION, LTD. or your healthcare provider for instructions. Notification method: E-Mail

About This Product

EverPatch is a surgical matrix intended to aid tissue integration during ocular procedures. It is used by surgeons in the operating room under medical supervision.

Why This Is Dangerous

If the conjunctival wound dehisces, the patch could become exposed prematurely, potentially complicating healing and necessitating additional procedures.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The recall may disrupt planned surgeries and require patients to undergo follow-up interventions. The issue creates safety and operational uncertainty for treatment teams.

Practical Guidance

How to identify if yours is affected

  1. Verify UDI on product labeling: All Lots/ UDI G16010362950
  2. Check packaging for recall notice and batch information
  3. Compare with the recall list to confirm eligibility

Where to find product info

UDI appears on the device labeling and patient device cards; the FDA recall page provides official details

What timeline to expect

Replacement or refund timelines typically 4-8 weeks after confirmation

If the manufacturer is unresponsive

  • Document all communications with the manufacturer
  • File a complaint with the relevant regulatory body if the company is unresponsive
  • Consult your surgeon for alternatives during the recall period

How to prevent similar issues

  • Before future implants, verify recall status and product numbers with the supplier
  • Ask clinicians to confirm lot numbers and UDI before use
  • Keep records of all device lot numbers and recall notices

Documentation advice

Retain all recall notices, correspondence with the manufacturer, and any medical records related to the affected device

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: All Lots/ UDI: G16010362950. Sold worldwide through healthcare distributors and providers. Sold since: Unknown. Price: Unknown. Quantity: 630 units.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Global distribution including US states listed and Japan, Israel, Argentina, Hong Kong
  • Hazard: conjunctival wound dehiscence leading to early patch exposure

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
All Lots/ UDI: G16010362950
Affected States
ALL
Report Date
October 15, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more